Inovio Pharmaceuticals, Inc. (INO)

Inovio Pharmaceuticals Statistics

Total Valuation

INO has a market cap or net worth of $137.09 million. The enterprise value is $46.92 million.

Market Cap	137.09M
Enterprise Value	46.92M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

INO has 25.96 million shares outstanding. The number of shares has increased by 12.16% in one year.

Shares Outstanding	25.96M
Shares Change (YoY)	+12.16%
Shares Change (QoQ)	+16.77%
Owned by Insiders (%)	1.60%
Owned by Institutions (%)	23.80%
Float	23.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	224.56
Forward PS	486.58
PB Ratio	1.49
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	79.28
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.45, with a Debt / Equity ratio of 0.13.

Current Ratio	4.45
Quick Ratio	4.25
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-151.38

Financial Efficiency

Return on equity (ROE) is -91.42% and return on invested capital (ROIC) is -47.25%.

Return on Equity (ROE)	-91.42%
Return on Assets (ROA)	-39.91%
Return on Capital (ROIC)	-47.25%
Revenue Per Employee	$4,851
Profits Per Employee	-$997,053
Employee Count	122
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.92% in the last 52 weeks. The beta is 0.82, so INO's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+18.92%
50-Day Moving Average	6.14
200-Day Moving Average	8.75
Relative Strength Index (RSI)	33.97
Average Volume (20 Days)	295,938

Short Selling Information

The latest short interest is 3.48 million, so 13.39% of the outstanding shares have been sold short.

Short Interest	3.48M
Short Previous Month	3.34M
Short % of Shares Out	13.39%
Short % of Float	14.80%
Short Ratio (days to cover)	9.33

Income Statement

In the last 12 months, INO had revenue of $591,858 and -$121.64 million in losses. Loss per share was -$5.09.

Revenue	591,858
Gross Profit	-76.17M
Operating Income	-117.12M
Pretax Income	-121.64M
Net Income	-121.64M
EBITDA	-114.99M
EBIT	-117.12M
Loss Per Share	-$5.09

Balance Sheet

The company has $110.42 million in cash and $12.98 million in debt, giving a net cash position of $97.44 million or $3.75 per share.

Cash & Cash Equivalents	110.42M
Total Debt	12.98M
Net Cash	97.44M
Net Cash Per Share	$3.75
Equity (Book Value)	96.74M
Book Value Per Share	3.73
Working Capital	91.16M

Cash Flow

In the last 12 months, operating cash flow was -$112.36 million and capital expenditures -$487,832, giving a free cash flow of -$112.84 million.

Operating Cash Flow	-112.36M
Capital Expenditures	-487,832
Free Cash Flow	-112.84M
FCF Per Share	-$4.35

Margins

Gross Margin	n/a
Operating Margin	-19,787.73%
Pretax Margin	-20,552.31%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-19,040.90%

Dividends & Yields

INO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.16%
Shareholder Yield	-12.16%
Earnings Yield	-84.26%
FCF Yield	-78.17%

Analyst Forecast

The average price target for INO is $21.17, which is 300.95% higher than the current price. The consensus rating is "Buy".

Price Target	$21.17
Price Target Difference	300.95%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	229.75%
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on January 25, 2024. It was a reverse split with a ratio of 0.0833333:1.

Last Split Date	Jan 25, 2024
Split Type	Reverse
Split Ratio	0.0833333:1

Scores

INO has an Altman Z-Score of -16.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-16.88
Piotroski F-Score	2